Calcium carbonate nanoparticles stimulate tumor metabolic reprogramming and modulate tumor metastasis

Nanomedicine (Lond). 2019 Jan;14(2):169-182. doi: 10.2217/nnm-2018-0302. Epub 2018 Dec 6.

Abstract

Aim: CaCO3 nanoparticles (nano-CaCO3) can neutralize the acidic pHe of solid tumors, but the lack of intrinsic imaging signal precludes noninvasive monitoring of pH-perturbation in tumor microenvironment. We aim to develop a theranostic version of nano-CaCO3 to noninvasively monitor pH modulation and subsequent tumor response.

Materials & methods: We synthesized ferromagnetic core coated with CaCO3 (magnetite CaCO3). Magnetic resonance imaging (MRI) was used to determine the biodistribution and pH modulation using murine fibrosarcoma and breast cancer models.

Results: Magnetite CaCO3-MRI imaging showed that nano-CaCO3 rapidly raised tumor pHe, followed by excessive tumor-associated acid production after its clearance. Continuous nano-CaCO3 infusion could inhibit metastasis.

Conclusion: Nano-CaCO3 exposure induces tumor metabolic reprogramming that could account for the failure of previous intermittent pH-modulation strategies to achieve sustainable therapeutic effect.

Keywords: MRI; magnetite; nano-CaCO; pH modulation; theranostic.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Calcium Carbonate* / pharmacology
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Female
  • Fibrosarcoma / drug therapy
  • Fibrosarcoma / pathology
  • Humans
  • Male
  • Mice
  • Nanoparticles / chemistry*
  • Neoplasm Metastasis / drug therapy*
  • Particle Size
  • Theranostic Nanomedicine
  • Tumor Microenvironment / drug effects*

Substances

  • Calcium Carbonate